300759 Pharmaron Beijing
- 19.25
- -1.39-6.73%
About Pharmaron Beijing Company
The company (stock code: 300759.SZ/3759.HK) is an international leading life science research and development service enterprise. Since its establishment in 2004, Kanglong Chemical has been committed to its talent training and facility construction, and has built an R&D and production service system throughout the entire process of drug discovery, pre-clinical and clinical development for multi-therapy drug research and development, including small molecules, macromolecules, and cell and gene therapy drugs. The company is engaged in drug research, development and production services, providing customers around the world with full-process integrated services for drug discovery and drug development. Products include small molecule chemicals, large molecule biopharmaceuticals, cell and gene therapy products, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- Boliang Lou
- Chairman，Executive Director，CEOs，Nomination Committee Members，Member of the Strategy Committee，Member of the Remuneration and Assessment Committee
- 2.21M
- jiaqing li
- Non-executive directors，Member of the Strategy Committee
- --
- xiaoqiang lou
- Executive Director，President，Member of the Strategy Committee，Member of the Remuneration and Assessment Committee，Chief Operating Officer
- 1.91M
- baifeng hu
- Non-executive directors
- --
- bei zheng
- Executive Director，Executive Vice President (Deputy Manager)，Nomination Committee Members
- 1.60M
- kunhongxiansheng ceng
- Independent Non-Executive Director，Nomination Committee Members，Member of the Remuneration and Assessment Committee，Audit Committee Member
- 220.00K
- jian yu
- Independent Non-Executive Director，Member of the Remuneration and Assessment Committee，Nomination Committee Members，Audit Committee Member
- 300.00K
- qilin zhou
- Independent Non-Executive Director，Member of the Strategy Committee
- 300.00K
- lihua li
- Independent Non-Executive Director，Nomination Committee Members，Member of the Audit Committee，Remuneration and Assessment Committee
- 300.00K
- Gilbert Shing Chung Li
- Board Secretary，Chief Financial Officer (Head of Finance)
- 6.89M
- Kexin Yang
- Chairman of the Supervisory Board，auditors
- 1.54M
- shu feng
- auditors
- --
- Hua Yang
- Chief Scientific Officer (Deputy Manager)，Core technical personnel
- 1.80M
- lan zhang
- Employee supervisors
- 829.80K
Analysis
Price Target
No Data
